Released	Title	Price Sensitive	Download	Types
2024-01-04 09:13:00	First Patient Dosed in Urothelial Cancer INSIGHT-005 Trial	0	https://app.sharelinktechnologies.com/announcement/asx/0681f63cab07a4c3339c60fc213712bf	Progress Report
2024-01-08 08:22:00	Immutep Corporate Presentation	0	https://app.sharelinktechnologies.com/announcement/asx/8eab8e68671a37661d3c8cedf1940b80	Company Presentation
2024-01-15 17:03:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/dddc7997dcc4a85236bde28e098ab7fa	Change in substantial holding
2024-01-30 08:32:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/f974b1158e6e9fe43fab9a64b21cf036	Commitments Test Entity - Second Quarter Report Commitments Test Entity - Second Quarter Activity Report
2024-01-31 19:31:00	Notification regarding unquoted securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/49b6c543ff2139acc7d4c3e029ab5a84	Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2024-02-14 09:12:00	Appointment of Non-Executive Director	0	https://app.sharelinktechnologies.com/announcement/asx/c5bf709600c2755d526d0876d9d4cced	Director Appointment/Resignation
2024-02-14 10:20:00	Appendix 3X - Anne Anderson	0	https://app.sharelinktechnologies.com/announcement/asx/b88c65f565f3f9ed4d4bbde429e16571	Initial Director's Interest Notice
2024-02-14 13:05:00	Ceasing to be a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/8c8900ee77c1a7169f41d4ad4edf0845	Ceasing to be a substantial holder
2024-02-15 16:45:00	Becoming a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/76ab17c47eabb7c014e14b4f46740c48	Becoming a substantial holder
2024-02-20 16:46:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/08a43b9d275c2c087e56e061fead178c	Change in substantial holding
2024-02-21 16:55:00	Immutep Investor Update	0	https://app.sharelinktechnologies.com/announcement/asx/1dbd4ec3cc065acdb862bfcfcfeb230e	Periodic Reports - Other Letter to Shareholders
2024-02-22 18:14:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/a6b56aa2a36b5858d438262606935a3f	Change in substantial holding
2024-02-26 16:47:00	Becoming a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/0e15d7a4803eb2318752c4ec8deb3e5e	Becoming a substantial holder
2024-02-28 09:39:00	Half Yearly Report and Accounts	1	https://app.sharelinktechnologies.com/announcement/asx/923355c17b6516dd53465405abacbd63	Half Yearly Report Half Year Audit Review Half Year Directors' Statement Half Year Accounts Half Year Directors' Report
2024-03-05 12:34:00	First Clinical Data announced from 90mg Dosing of Efti	1	https://app.sharelinktechnologies.com/announcement/asx/e7eb8029b775cc6ef3029596453570a0	Progress Report
2024-03-08 16:27:00	Ceasing to be a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/5072a2741ccc5e921edc61a6523422b6	Ceasing to be a substantial holder
2024-04-11 18:30:00	Ceasing to be a substantial holder	0	https://app.sharelinktechnologies.com/announcement/asx/4a319c100c2afa915652dcdaae237244	Ceasing to be a substantial holder
2024-04-17 09:10:00	Positive Feedback received from Spanish Medicines Agency	0	https://app.sharelinktechnologies.com/announcement/asx/d43894001dafa767ff0f66e980d8cca2	Progress Report
2024-04-18 09:36:00	CHDR to conduct first-in-human phase 1 trial of IMP761	1	https://app.sharelinktechnologies.com/announcement/asx/a98578c19ebb71f188e1e45a50925906	Progress Report
2024-04-24 08:40:00	Positive preliminary topline results from TACTI-003 Cohort B	1	https://app.sharelinktechnologies.com/announcement/asx/b2451fe39828d6a3bc21477964b57aff	Progress Report
2024-04-29 08:18:00	Immutep Quarterly Activities Report and Appendix 4C	1	https://app.sharelinktechnologies.com/announcement/asx/35d064011d471f1cca85165ef4aaee1a	Commitments Test Entity - Third Quarter Report Commitments Test Entity - Third Quarter Activity Report
2024-05-02 09:29:00	Positive initial data in phase 2 Soft Tissue Sarcoma trial	1	https://app.sharelinktechnologies.com/announcement/asx/24f49f8204f4760123e9087c622c4511	Progress Report
2024-05-15 18:01:00	AIPAC-003 safety lead-in data presented at ESMO Breast 2024	1	https://app.sharelinktechnologies.com/announcement/asx/9eb3278d9e3ac507acecc898dd73301e	Progress Report
2024-06-03 08:51:00	Trading Halt	1	https://app.sharelinktechnologies.com/announcement/asx/43f1ca7e5e47afbb3884635083c1902e	Trading Halt
2024-06-03 09:14:00	A$100 million fully underwritten equity raising	1	https://app.sharelinktechnologies.com/announcement/asx/26136f6e9e3d0db0120f09828ba9abb9	Placement Non-Renounceable Issue
2024-06-03 09:19:00	Immutep Capital Raising Presentation	1	https://app.sharelinktechnologies.com/announcement/asx/799ffde1268524e73b1f875e31347238	Company Presentation
2024-06-03 09:28:00	Proposed issue of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/95995a9bf07a9771fcdb4c8f820c1910	Appendix 3B
2024-06-03 09:41:00	Immutep announces Ph 3 clinical trial collaboration with MSD	1	https://app.sharelinktechnologies.com/announcement/asx/fe0d6f7ca0f0591ba6df1946be184838	Progress Report
2024-06-03 10:00:00	Cleansing Notice	0	https://app.sharelinktechnologies.com/announcement/asx/694b4b2625b95c2b2fd0acde10dec370	Cleansing Notice
2024-06-05 09:11:00	Immutep completes institutional pro-rata offer & placement	1	https://app.sharelinktechnologies.com/announcement/asx/3ff9d50f9b9307e6bf606cccefcaf8f2	Placement Non-Renounceable Issue Trading Halt Lifted
2024-06-07 12:53:00	Immutep retail entitlement offer booklet	0	https://app.sharelinktechnologies.com/announcement/asx/088affa7bb319d3fcff0726c9469c5ef	Non-Renounceable Issue Disclosure Document
2024-06-07 13:02:00	Immutep letter to ineligible shareholders	0	https://app.sharelinktechnologies.com/announcement/asx/ee732df5d1565b5a4475b6225170d9a3	Non-Renounceable Issue Letter to Shareholders
2024-06-12 09:30:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/818307d8f0d9ff4155f9c5be6b140e28	Appendix 2A (Application for Quotation of Securities
2024-06-12 10:10:00	Cleansing Notice	0	https://app.sharelinktechnologies.com/announcement/asx/94830e3d827e21f8c3e4c39f6fa048b1	Cleansing Notice
2024-06-14 08:19:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/9cc703c46fe703f60d717ab0ac181af2	Change in substantial holding
2024-06-14 16:49:00	Change in substantial holding	0	https://app.sharelinktechnologies.com/announcement/asx/99ce5e7eff1927f5e3bdc9e29739693a	Change in substantial holding
2024-06-18 12:16:00	Change in substantial holding from IFL	0	https://app.sharelinktechnologies.com/announcement/asx/1502c85a799a8961d3f3b9ccf8068cdd	Change in substantial holding
2024-06-24 13:53:00	Immutep completes underwritten retail entitlement offer	1	https://app.sharelinktechnologies.com/announcement/asx/9babeb08b25b0f91ba73adb9a30b2b22	Non-Renounceable Issue Issued Capital - Other
2024-06-25 08:16:00	Immutep signs agreement for anti-LAG-3 small molecules	0	https://app.sharelinktechnologies.com/announcement/asx/6d9a36a3f6f55e5f4bc8e20adab8ca98	Progress Report
2024-06-25 08:59:00	Application for quotation of securities - IMM	0	https://app.sharelinktechnologies.com/announcement/asx/b1de55ba56e3ebf02d8f12ced083102e	Appendix 2A (Application for Quotation of Securities
2024-06-27 08:09:00	Positive topline results from ph2b in head & neck cancer	1	https://app.sharelinktechnologies.com/announcement/asx/01c5467c4a7bfb7ff699b32dd8adcd34	Progress Report
2024-06-27 08:31:00	Webcast slides for new Efti clinical data in 1st line HNSCC	1	https://app.sharelinktechnologies.com/announcement/asx/b235b06f7415ed3bc29fec34729a0282	Company Presentation
2024-07-03 08:33:00	Details for Immutep Webcast & ESMO Virtual Plenary Session	0	https://app.sharelinktechnologies.com/announcement/asx/85d22153acabcc162a340f52533bea2a	Web Casts